Loading company…
PhaseRx develops mRNA therapies for inherited liver defects and other rare childhood diseases.
Founded in 2006 and based in Seattle, US, PhaseRx develops mRNA therapies for inherited liver defects and other rare diseases affecting children.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in